FDA approves Edwards’ TAVR system for asymptomatic aortic stenosis patients
The FDA has approved Edwards Lifesciences' SAPIEN 3 TAVR platform for the treatment of patients with asymptomatic severe aortic stenosis (AS). The post FDA approves Edwards’ TAVR system for asymptomatic aortic stenosis patients appeared first on Medical Device Network.
The FDA has approved Edwards Lifesciences' SAPIEN 3 TAVR platform for the treatment of patients with asymptomatic severe aortic stenosis (AS).
The post FDA approves Edwards’ TAVR system for asymptomatic aortic stenosis patients appeared first on Medical Device Network.
